andere Bezeichnungen
- Parkinson Krankheit
- Morbus Parkinson
Parkinson
Die Parkinson-Krankheit ist ein langsam fortschreitender Verlust von Nervenzellen. Als neurodegenerative Erkrankung zählt sie zu den degenerativen Erkrankungen des extrapyramidal-motorischen Systems.
Hauptwirksame Cannabinoide
- CBC
- CBD (Cannabidiol)
- CBG
- CBN
- Δ⁹-THC
Studien/Artikel zur Behandlung von Parkinson mit Cannabis-Medikation
- Clinical Studies and Case Reports
- Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.
- The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes.
- Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease Induced by MPTP.
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial.
- Prospects for cannabinoid therapies in basal ganglia disorders.
- Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: importance of antioxidant and cannabinoid receptor-independent properties.
- Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease.
- Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series.
- β-Caryophyllene (BCP) ameliorates MPP+ induced cytotoxicity.
- Cannabidiol for the treatment of psychosis in Parkinson’s disease.
- Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson’s disease.
- Therapeutic potential of cannabinoids in CNS disease.
- Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease.
- Link Wikipedia (DE)